Open Access

Supplementing alpha-tocopherol (vitamin E) and vitamin D3 in high fat diet decrease IL-6 production in murine epididymal adipose tissue and 3T3-L1 adipocytes following LPS stimulation

  • Fábio S Lira1,
  • José C Rosa1,
  • Claudio A Cunha1,
  • Eliane B Ribeiro1,
  • Claudia Oller do Nascimento1Email author,
  • Lila M Oyama1 and
  • João F Mota1
Lipids in Health and Disease201110:37

DOI: 10.1186/1476-511X-10-37

Received: 15 December 2010

Accepted: 27 February 2011

Published: 27 February 2011

Abstract

Background

It is well known that high fat diets (HFDs) induce obesity and an increase in proinflammatory adipokines. Interleukin-6 (IL-6) is considered the major inflammatory mediator in obesity. Obesity is associated with a vitamin deficiency, especially of vitamins E and D3. We examined the effects of vitamin D3 and vitamin E supplementation on levels of IL-6 and IL-10 (as a marker of anti-inflammatory cytokines since, a balance between pro- and anti-inflammatory cytokines is maintained) protein expression in adipose tissue of mice provided with an HFD. Additionally, we measured the effects of vitamin E and vitamin D3 treatment on LPS-stimulated 3T3-L1 adipocytes IL-6 and IL-10 secretion.

Results

IL-6 protein levels and the IL-6/IL-10 ratio were decreased in epididymal white adipose tissue in groups receiving vitamins E and D3 supplementation compared to the HFD group. A 24-hour treatment of vitamin D3 and vitamin E significantly reduced the IL-6 levels in the adipocytes culture medium without affecting IL-10 levels.

Conclusions

Vitamin D3 and vitamin E supplementation in an HFD had an anti-inflammatory effect by decreasing IL-6 production in epididymal adipose tissue in mice and in 3T3-L1 adipocytes stimulated with LPS. Our results suggest that vitamin E and D3 supplementation can be used as an adjunctive therapy to reduce the proinflammatory cytokines present in obese patients.

Introduction

The incidence of obesity has dramatically increased during the past several decades [1]. In 2006, the World Health Organization estimated that 1.6 billion adults worldwide were overweight and 400 million adults were obese [2]. Although morbidly obese people have a greater food intake than non-obese people, they may suffer from nutritional deficiencies.

High fat diets (HFDs) contribute to the accumulation of adipose tissue, resulting in obesity and possibly insulin resistance. Adipose tissue secretes soluble factors called adipokines, which include pro-inflammatory cytokines. It is known that long-term low systemic inflammation that occurs in obese individuals contributes to the development of metabolic syndrome [3]. Lira et al. [4] reported that body fat correlates with cytokine levels, and it was demonstrated that increased body fat was associated with elevated cytokine levels in obese adolescents. Tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6), which are increased in obese subjects, may downregulate adiponectin production. In contrast, adiponectin reduces the production and activity of TNF-α and IL-6. IL-6 is considered the major inflammatory mediator in obesity. IL-6 has been implicated in the release of triglycerides and free fatty acids, downregulated lipoprotein lipase, insulin resistance, increased production of reactive oxygen species and decreased nitric oxide generation [5].

IL-10, which is an anti-inflammatory cytokine, may antagonize the actions of IL-6 [5]. Recently, Hong et al. (2010) demonstrated that IL-10 increases insulin sensitivity, protects from obesity-associated macrophage infiltration, prevents increases in proinflammatory cytokines and may prevent the deleterious actions of pro-inflammatory cytokines on insulin signaling and glucose metabolism [6].

Obesity is associated with vitamin deficiencies. Low concentrations of 25-hydroxyvitamin D3 have been associated with an increased risk of diabetes and other cardiovascular disease risk factors [7]. In patients with metabolic syndrome, six weeks of alpha-tocopherol supplementation reduced serum levels of TNF-α [8].

Antioxidant micronutrients have been proposed as adjunctive therapy in patients with diabetes [9]. Indeed, some minerals and vitamins are able to participate indirectly in the reduction of oxidative stress in diabetic patients by improving glycemic control and/or exerting antioxidant activity. For example, Foss [10] speculated that vitamin D deficiency is the cause of obesity, which can be reversed by improving the levels of vitamin D. On the contrary, Czernichow and colleagues [11] demonstrated that the incidence of metabolic syndrome was reduced in healthy individuals that were given an anti-oxidant formula containing vitamin E, vitamin C, beta-carotene, zinc and selenium.

Our hypothesis is that the well established proinflammatory effect of HFD ingestion on white adipose tissue could be reduced by supplementation of vitamin D3 and alpha-tocopherol (vitamin E). The aim of this study was to examine the effects of vitamins D3 and E supplementation on the levels of IL-6 and IL-10 protein expression in adipose tissue of mice provided with a HFD. Additionally, we evaluated the effects of vitamin E and vitamin D3 on 3T3-L1 adipocytes stimulated with LPS in terms of IL-6 and IL-10 secretion.

Materials and methods

The Experimental Research Committee of the São Paulo Federal University approved all procedures for the care of the animals used in this study (protocol n°2007/0388). Thirty-day-old male Swiss mice were used in this study and were kept under controlled conditions (12 h light: 12 h dark cycle with lights on at 07:00; 22°C ± 1°C). During the experimental period, the animals were group-housed and provided water and a specific diet ad libitum. The animals were treated for eight weeks as follows: 1) HFD - Twelve animals were treated for eight weeks with a hyperlipidic diet based on the AIN93 formulation with 20% of the fat from soya beans; 2) HFD Vitamin D3 - Twelve animals were treated for four weeks with a hyperlipidic diet based on the AIN93 formulation with 20% of the fat from soya beans and an additional four weeks with the same diet supplemented with 1,25(OH)2 vitamin D3 (0.05 mg/Kg of diet); and 3) HFD Vitamin E - Twelve animals were treated for four weeks with a hyperlipidic diet based on the AIN93 formulation with 20% of the fat from soya beans and an additional four weeks with the same diet supplemented with alpha-tocopherol (0.9 g/kg of diet). The animals' weight and food intake were evaluated weekly.

Sample collection

After eight weeks the animals were euthanized by decapitation without sedation. Retroperitoneal, mesenteric and epididymal fat pads were removed and weighed to estimate the degree of obesity. Samples of epididymal white adipose tissue were dissected, immediately frozen in liquid nitrogen and stored at -80°C.

Cell culture

3T3-L1 cells were obtained from the American Type Culture Collection and cultured at a 37°C, 5% CO2 and 95% humidity. The cells were maintained in Dulbecco's Eagle modified medium (DMEM) supplemented with 25 mM glucose, 1.0 mM pyruvate, 4.02 mM L-alanyl-glutamine and 10% fetal bovine serum (FBS) (Gibco). The cells were differentiated 24 h after reaching confluency for 4 days in a medium containing 0.25 μM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and 5 μg/mL insulin (Sigma). After the cells were differentiated, the cells were cultured for 8 days in growth medium containing 5 μg/ml of insulin.

Treatment

Eight days after the differentiation, the cells were pretreated with medium containing vitamin D3 (10-7 M) (1,25(OH)2 vitamin D3) and vitamin E (50 μM - alpha-tocopherol) for 24 h. Cells were then treated with the same medium along with LPS (75 ng/ml) for an additional 24 h before being harvested. No vitamins were added to the control plates, but the medium was changed. The cultured medium was collected in tubes and stored at -80°C.

Analysis of IL-6 and IL-10 levels

Adipose tissue samples were carefully rinsed in ice-cold 0.9% NaCl to remove any blood contaminants, snap frozen in liquid nitrogen, and stored at -80°C. Frozen tissue (0.1 g - 0.3 g) was homogenized in RIPA buffer (0.625% Nonidet P-40, 0.625% sodium deoxycholate, 6.25 mM sodium phosphate and 1 mM ethylenediamine tetraacetic acid at pH 7.4) containing 10 mg/ml protease inhibitor cocktail (Sigma-Aldrich, St. Louis, Missouri). Homogenates were centrifuged at 12,000 g for 10 min at 4°C. The supernatant was saved and protein concentration was determined by a Bradford assay (Bio-Rad, Hercules, CA) using bovine serum albumin (BSA) as a standard. Levels of IL-6 and IL-10 in adipose tissue and medium culture were quantified by ELISA (DuoSet ELISA, R & D Systems, Minneapolis, MN). The IL-6 (DY506) and IL-10 (DY522) assay sensitivities were found to be 5.0 pg/ml in the range of 31.2 - 2000 pg/ml. The intra- and inter-assay variability of the IL-6 and IL-10 kits was 2.7-5.2% and 4.9-9.5%, respectively. The intra-assay variability of the IL-6 and IL-10 kits was 2.0-4.2%, and the inter-assay variability was 3.3-6.4%. All samples were run as duplicates, and the mean values are reported.

Statistical analysis

The results are expressed as a mean ± S.D. For statistical analysis, a one-way ANOVA was used to compare the treatment effects (presence or absence of vitamin D3 and vitamin E). Tukey's test was applied for comparison of the results within the means, and p < 0.05 was considered statistically significant.

Results

In vivo study

Vitamin D3 and vitamin E supplementation decreased the body weight gain in mice provided with an HFD (39%, p < 0.01 and 48%, p < 0.001, respectively). However, the adiposity index and energy intake were similar among the studied groups (Table 1).
Table 1

Body weight again, epididymal adipose tissue weight, adiposity index and cytokines levels

 

High Fat

High Fat plus Vit.D

High Fat plus Vit.E

Body weight gain (g)

19.95 ± 4.47a

12.08 ± 4.59b

10.40 ± 2.46b

Energy intake (KJ/100 g b.w)

10272 ± 584a

10686 ± 495a

10686 ± 495a

Vitamin E intake (mg)

16.6 ± 2.4a

18.34 ± 1.17a

202.07 ± 17.88b

Vitamin D3 intake (mg)

0.049 ± 0.007a

0.064 ± 0.004b

0.051 ± 0.001a

Epididymal WAT weight (g)

1.01 ± 0.21a

0.72 ± 0.18a

0.88 ± 0.34a

Adiposity index (g)

1.86 ± 0.50a

1.29 ± 0.35a

1.33 ± 0.55a

IL-6 (pg/ug protein -1 )

115.88 ± 48.01a

66.29 ± 20.97b

44.94 ± 8.49b

IL-10 (pg/ug protein -1 )

28.46 ± 10.18a

43.42 ± 14.06a

32.30 ± 2.24a

IL-6/IL-10

3.23 ± 1.55a

1.63 ± 0.68b

1.39 ± 0.27b

Results are expressed as mean value ± SD. Vitamin consumption during the study. Different letters indicate statistically significant differences (p < 0.05).

IL-6 protein content in epididymal adipose tissue (WAT) was reduced (p < 0.05) by vitamin D3 (32%) and vitamin E (61%) supplementation in mice treated with HFD. Similar IL-10 WAT protein content was observed among the groups, although the IL-6/IL-10 ratio was reduced in groups supplemented with vitamins in relation to the HFD group, (vitamin D3: 50%, and vitamin E: 57%, p < 0.01) (Table 1).

In vitro study

Twenty-four hours of LPS treatment caused an increase in both IL-6 (approximately 14-fold) and IL-10 protein concentration in 3T3-L1 adipocytes culture medium. The IL-10 protein was not detectable in the control medium.

Twenty-four hours of supplementation with vitamin D3 and vitamin E in the adipocytes stimulated with LPS significantly reduced the levels of IL-6 (88% and 60%, respectively; p < 0.01) in the culture medium without any effect on the IL-10 levels (Table 2). Vitamin D3 and E reduced the IL-6/IL-10 ratio in adipocytes stimulated with LPS (Table 2).
Table 2

Cytokine levels in 3T3-L1

 

Control

LPS

LPS plus Vit.D

LPS plus Vit.E

IL-6 (pg/ug protein -1 )

0.272 ± 0.034a

36.80 ± 16.08b

4.36 ± 2.16a

14.54 ± 4.95c

IL-10 (pg/ug protein -1 )

ND

55.88 ± 4.84b

56.95 ± 5.25b

58.94 ± 5.50b

IL-6/IL-10

-

0.67 ± 0.09a

0.08 ± 0.01b

0.25 ± 0.03b

Results are expressed as mean value ± SD. ND: no detectable. Different letters indicate statistically significant differences (p < 0.05).

Discussion

Supplementation of vitamin D3 and vitamin E reduced proinflammatory cytokine production by the WAT from the HFD-fed mice. In the 3T3-L1 adipocytes, LPS stimulated IL-6 and IL-10 production. Addition of vitamins D3 and E in the culture medium with LPS significantly reduced IL-6 levels without altering IL-10 levels. These results suggest the importance of vitamins, both in vivo and in vitro, in controlling the inflammatory state in adipocytes.

Obesity occurs due to a complex combination of multiple environmental and genetic factors. Consumption of highly energetic, fatty, and palatable foods is the most important epidemiological predisposing factors to obesity development [12, 13]. Studies have shown that the increase in the production of adipokines, such as PAI-1 [14], TNF-α [15] and IL-6, [16], and the reduction of adiponectin [17] are critically involved in the pathogenesis of obesity.

HFD causes lipotoxic impairment of insulin action and the regulatory mechanisms of body weight [18]. Mice fed with HFD supplemented with vitamin E and vitamin D3 had a slight gain in body weight without changes in the adiposity index and energy intake, which suggested an increase in thermogenesis and metabolic rate.

Several studies have shown an inverse association of serum vitamin D3 levels with adiposity and body mass index [1922]. In addition, it has been demonstrated that blockade of 3T3-L1 cell differentiation by vitamin D3 involves C/EBPβ suppression, PPARγ upregulation, and antagonist function of PPARγ activity [23, 24].

However, Wong et al. [22] demonstrated that vitamin D receptor-null mice have a higher rate of fatty acid beta-oxidation and an up regulation of uncoupling protein (UCP) 1, UCP2 and UCP3 expression in the WAT. They also demonstrated that 1,25-dihydroxyvitamin D3 directly suppressed the expression of the UCPs in primary brown fat culture. They concluded that vitamin D3 is involved in energy metabolism and adipocyte biology in vivo in part through regulation of beta-oxidation and UCP expression. The difference between this study and the present study may be due to differences in the protocols that were used.

Furthermore, Sun and Zemel [23] showed that calcitriol increased production of reactive oxygen species (ROS) by inhibiting UCP2 expression and stimulating intracellular calcium influx, resulting in fatty acid synthesis and lipolysis inhibition. However, Zembel and Sun [24] suggested that calcitriol exerts a dose-dependent impact on adipocyte apoptosis, indicating that a low physiological dose inhibits apoptosis and a pharmacological dose stimulates apoptosis. More studies are necessary to understand the effects of HFD with vitamin D3 and vitamin E supplementation on body weight gain and thermogenesis.

The effect of vitamin E supplementation on body mass index is not conclusive. Botella-Carretero and colleagues [25] demonstrated an inverse correlation between vitamin E and body mass index, whereas other studies have reported no correlation [26, 27].

Obesity and insulin resistance are associated with low grade chronic systemic inflammation [28]. In models of diet-induced obesity and genetic obesity, the adipose tissue has increased expression of proinflammatory cytokines, such as TNF-α, IL-1, and IL-6 [15, 29]. Furthermore, fatty acids increased IL-6 serum concentration and gene expression in adipocytes [30], and a saturated fat-rich diet increased IL-6 concentrations in human adipocytes [31]. The main result of our study is that treatment with vitamin D3 and vitamin E reduces IL-6 levels in epididymal adipose tissue (in vivo) and 3T3-L1 adipocytes (in vitro).

Low concentrations of vitamin D is the most common vitamin deficiency associated with obesity and may be closely linked to the increase in ROS which activates the inflammatory pathway [7]. There is evidence that insulin resistance results from the proinflammatory cytokines actions released from the adipose tissue, such as TNF-α and IL-6 [32].

Production of IL-6 increases with adiposity, and circulating IL-6 concentrations are highly correlated with percentage of body fat and insulin resistance [33]. Vitamin E supplementation in patients with diabetes decreases the levels of proinflammatory cytokines, such as IL-1, TNF-α, IL-6, and reactive C protein, in serum and stimulated monocytes [34, 35]. In addition, high intake of foods rich in vitamin E demonstrated an inverse correlation with levels of C reactive protein and IL-6 [36]. Elevated TNF-α concentrations cause stress oxidation in monocytes which, conversely, increases low density lipoprotein (LDL) oxidation [37]. Oxidative modification of lipoproteins is an essential component of the atherogenic process [34]. Manning et al. (2004) showed that vitamin E supplementation decreased plasma peroxide concentration in obese individuals [26]. In the present study, we demonstrated that a vitamin D3- and vitamin E-supplemented diet decreases IL-6 levels in adipose tissue and in 3T3-L1 adipocytes. Taken together, these results demonstrate that vitamin E and vitamin D3 could have a direct effect on adipocytes.

In conclusion, vitamin D3 and vitamin E supplementation in HFD had an anti-inflammatory effect by decreasing IL-6 production in epididymal adipose tissue in mice and in 3T3-L1 adipocytes stimulated with LPS. Potentially, our results suggest that vitamin E and D3 supplementation can be used as an adjunctive therapy to reduce proinflammatory cytokines levels in obese patients.

Declarations

Acknowledgements

This work was supported by FAPESP (grants n°07/53444-2 and 08/54733-0).

Authors’ Affiliations

(1)
Departamento de Fisiologia, Universidade Federal de São Paulo

References

  1. Caballero B: The global epidemic of obesity: an overview. Epidemiol Rev. 2007, 29: 1-5. 10.1093/epirev/mxm012View ArticlePubMedGoogle Scholar
  2. World Health Organisation (WHO): Obesity and overweight. 2006, http://www.who.int/mediacentre/factsheets/fs311/en/index.htmlGoogle Scholar
  3. Lee IS, Shin G, Choue R: Shifts in diet from high fat to high carbohydrate improved levels of adipokines and pro-inflammatory cytokines in mice fed a high-fat diet. Endocr J. 2010, 57: 39-50. 10.1507/endocrj.K09E-046View ArticlePubMedGoogle Scholar
  4. Lira FS, Rosa JC, Dos Santos RV, Venancio DP, Carnier J, Sanches PD, do Nascimento CM, de Piano A, Tock L, Tufik S, de Mello MT, Dâmaso AR, Oyama LM: Visceral fat decreased by long-term interdisciplinary lifestyle therapy correlated positively with interleukin-6 and tumor necrosis factor-alpha and negatively with adiponectin levels in obese adolescents. Metabolism. 2011, 60 (3): 359-65. 10.1016/j.metabol.2010.02.017View ArticlePubMedGoogle Scholar
  5. Eder K, Baffy N, Falus A, Fulop AK: The major inflammatory mediator interleukin-6 and obesity. Inflamm Res. 2009, 58: 727-36. 10.1007/s00011-009-0060-4View ArticlePubMedGoogle Scholar
  6. Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, Yu TY, Friedline RH, Kurt-Jones E, Finberg R, Fischer MA, Granger EL, Norbury CC, Hauschka SD, Philbrick WM, Lee CG, Elias JA, Kim JK: Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes. 2009, 58: 2525-35. 10.2337/db08-1261PubMed CentralView ArticlePubMedGoogle Scholar
  7. Aasheim ET, Hofsø D, Hjelmesaeth J, Birkeland KI, Bøhmer T: Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr. 2008, 87: 362-9.PubMedGoogle Scholar
  8. Devaraj S, Leonard S, Traber MG, Jialal I: Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med. 2008, 44: 1203-8. 10.1016/j.freeradbiomed.2007.12.018PubMed CentralView ArticlePubMedGoogle Scholar
  9. Bonnefont-Rousselot D: The role of antioxidant micronutrients in the prevention of diabetic complications. Treat Endocrinol. 2004, 3: 41-52. 10.2165/00024677-200403010-00005View ArticlePubMedGoogle Scholar
  10. Foss YJ: Vitamin D deficiency is the cause of common obesity. Med Hypotheses. 2009, 72: 314-21. 10.1016/j.mehy.2008.10.005View ArticlePubMedGoogle Scholar
  11. Czernichow S, Vergnaud AC, Galan P, Arnaud J, Favier A, Faure H, Huxley R, Hercberg S, Ahluwalia N: Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr. 2009, 90: 329-35. 10.3945/ajcn.2009.27635View ArticlePubMedGoogle Scholar
  12. Galgani J, Ravussin E: Energy metabolism, fuel selection and body weight regulation. Int J Obes. 2008, 32: S109-19. 10.1038/ijo.2008.246.View ArticleGoogle Scholar
  13. Hill JO, Melanson EL, Wyatt HT: Dietary fat intake and regulation of energy balance: implications for obesity. J Nutr. 2000, 130: 284S-288S.PubMedGoogle Scholar
  14. Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y: Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med. 1996, 2: 800-3. 10.1038/nm0796-800View ArticlePubMedGoogle Scholar
  15. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993, 259: 87-91. 10.1126/science.7678183View ArticlePubMedGoogle Scholar
  16. Fried SK, Bunkin DA, Greenberg AS: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998, 83: 847-50. 10.1210/jc.83.3.847PubMedGoogle Scholar
  17. Bueno AA, Oyama LM, de Oliveira C, Pisani LP, Ribeiro EB, Silveira VL, Oller do Nascimento CM: Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1cells and C57BL/6J mice adipose tissue. Pflugers Arch. 2008, 455: 701-9. 10.1007/s00424-007-0330-3View ArticlePubMedGoogle Scholar
  18. Magnan C, Collins S, Berthault MF, Kassis N, Vincent M, Gilbert M, Pénicaud L, Ktorza A, Assimacopoulos-Jeannet F: Lipid infusion lowers sympathetic nervous activity and leads to increased beta-cell responsiveness to glucose. J Clin Invest. 1999, 103: 413-9. 10.1172/JCI3883PubMed CentralView ArticlePubMedGoogle Scholar
  19. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, Yanovski JA: The relationship between obesity and serum 1, 25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004, 89: 1196-9. 10.1210/jc.2003-031398View ArticlePubMedGoogle Scholar
  20. van Dam RM, Snijder MB, Dekker JM, Stehouwer CD, Bouter LM, Heine RJ, Lips P: Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study. Am J Clin Nutr. 2007, 85: 755-61.PubMedGoogle Scholar
  21. Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R: Serum 1, 25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr. 2008, 47: 87-91. 10.1007/s00394-008-0700-4View ArticlePubMedGoogle Scholar
  22. Wong KE, Szeto FL, Zhang W, Ye H, Kong J, Zhang Z, Sun XJ, Li YC: Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab. 2009, 296: E820-8. 10.1152/ajpendo.90763.2008PubMed CentralView ArticlePubMedGoogle Scholar
  23. Sun X, Zemel MB: 1Alpha, 25-dihydroxyvitamin D3 modulation of adipocyte reactive oxygen species production. Obesity. 2007, 15: 1944-53. 10.1038/oby.2007.232View ArticlePubMedGoogle Scholar
  24. Zemel MB, Sun X: Calcitriol and energy metabolism. Nutr Rev. 2008, 66: S139-46. 10.1111/j.1753-4887.2008.00099.xView ArticlePubMedGoogle Scholar
  25. Botella-Carretero JI, Balsa JA, Vázquez C, Peromingo R, Díaz-Enriquez M, Escobar-Morreale HF: Retinol and alpha-Tocopherol in Morbid Obesity and Nonalcoholic Fatty Liver Disease. Obes Surg. 2010, 20: 69-76. 10.1007/s11695-008-9686-5View ArticlePubMedGoogle Scholar
  26. Manning PJ, Sutherland WH, Walker RJ, Williams SM, De Jong SA, Ryalls AR, Berry EA: Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care. 2004, 27: 2166-71. 10.2337/diacare.27.9.2166View ArticlePubMedGoogle Scholar
  27. Sutherland WH, Manning PJ, Walker RJ, de Jong SA, Ryalls AR, Berry EA: Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects. Obesity. 2007, 15: 386-91. 10.1038/oby.2007.546View ArticlePubMedGoogle Scholar
  28. Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest. 2005, 115: 1111-9.PubMed CentralView ArticlePubMedGoogle Scholar
  29. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003, 112: 1796-808.PubMed CentralView ArticlePubMedGoogle Scholar
  30. Zhou Q, Du J, Hu Z, Walsh K, Wang XH: Evidence for adipose-muscle cross talk: opposing regulation of muscle proteolysis by adiponectin and Fatty acids. Endocrinology. 2007, 148: 5696-705. 10.1210/en.2007-0183View ArticlePubMedGoogle Scholar
  31. Baer DJ, Judd JT, Clevidence BA, Tracy RP: Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr. 2004, 79: 969-73.PubMedGoogle Scholar
  32. Nishimatsu H, Suzuki E, Takeda R, Takahashi M, Oba S, Kimura K, Nagano T, Hirata Y: Blockade of endogenous proinflammatory cytokines ameliorates endothelial dysfunction in obese Zucker rats. Hypertens Res. 2008, 3: 737-43. 10.1291/hypres.31.737.View ArticleGoogle Scholar
  33. Wisse BE: The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004, 15: 2792-800. 10.1097/01.ASN.0000141966.69934.21View ArticlePubMedGoogle Scholar
  34. Devaraj S, Jialal I: Antioxidants and vitamins to reduce cardiovascular disease. Curr Atheroscler Rep. 2000, 2: 342-51. 10.1007/s11883-000-0069-1View ArticlePubMedGoogle Scholar
  35. Upritchard JE, Sutherland WH, Mann JI: Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care. 2000, 23: 733-8. 10.2337/diacare.23.6.733View ArticlePubMedGoogle Scholar
  36. Helmersson J, Arnlöv J, Larsson A, Basu S: Low dietary intake of betacarotene, alphatocopherol and ascorbic acid is associated with increased inflammatory and oxidative stress status in a Swedish cohort. Br J Nutr. 2009, 101: 1775-82. 10.1017/S0007114508147377View ArticlePubMedGoogle Scholar
  37. Li Q, Cathcart MK: Protein kinase C activity is required for lipid oxidation of low density lipoprotein by activated human monocytes. J Biol Chem. 1994, 269: 17508-15.PubMedGoogle Scholar

Copyright

© Lira et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.